Phibro Animal Health (PAHC) Tops Q1 EPS by 7c, Revenues Beat; Offers 2Q Revenue Guidance Below Consensus, 2Q EPS Mid-Point Guidance Below Consensus

Go back to Phibro Animal Health (PAHC) Tops Q1 EPS by 7c, Revenues Beat; Offers 2Q Revenue Guidance Below Consensus, 2Q EPS Mid-Point Guidance Below Consensus

 Phibro Animal Health Corporation Reports Second Quarter Results

February 3, 2021 4:45 PM EST

TEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced financial results for its second quarter ended December 31, 2020.

Highlights for the December 31, 2020 quarter (compared to the quarter ended December 31, 2019)

Net sales of $206 million, a decrease of $8 million, or 4% Net income of $13 million, an increase of $1 million, or 8% Diluted EPS of $0.32, an increase of $0.03, or 10%. Adjusted EBITDA of $29 million, comparable to the prior year Adjusted Net Income of $14 million, comparable to the prior year Adjusted diluted EPS of $0.34, comparable... More